Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

22nd Century Group, Inc. XXII NASDAQ

NASDAQ Capital Marke • Consumer Defensive • Tobacco • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$82.50
+3924.4%

22nd Century Group, Inc. (XXII) is a Tobacco company in the Consumer Defensive sector, currently trading at $2.05. It has a SharesGrow Score of 43/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Analyst consensus target is XXII = $83 (+3924.4% upside).

Valuation: XXII trades at a trailing Price-to-Earnings (P/E) of -0.1 (S&P 500 average ~25).

Financials: revenue is $18M, -21.1%/yr average growth. Net income is $5M (loss), growing at +6.8%/yr. Net profit margin is -28.7% (negative). Gross margin is -20.2% (-22.1 pp trend).

Balance sheet: total debt is $4M against $16M equity (Debt-to-Equity (D/E) ratio 0.27, conservative). Current ratio is 2.42 (strong liquidity). Debt-to-assets is 15.6%. Total assets: $27M.

Analyst outlook: 6 / 8 analysts rate XXII as buy (75%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 40/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 0/100 (Fail), Future 85/100 (Pass), Income 10/100 (Fail).

$82.50
▲ 3924.39% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for 22nd Century Group, Inc., the average price target is $82.50, with a high forecast of $90.00, and a low forecast of $75.00.
Highest Price Target
$90.00
Average Price Target
$82.50
Lowest Price Target
$75.00

XXII SharesGrow Score Overview

60/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 85/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — XXII

✓
VALUE Pass
100/100
XXII trades at a trailing Price-to-Earnings (P/E) of -0.1 (S&P 500 average ~25). Analyst consensus target is $83, implying +3948.8% from the current price $2. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
40/100
XXII: -21.1%/yr revenue is, +6.8%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet XXII: Debt-to-Equity (D/E) ratio 0.27 (conservative), Current ratio is 2.42 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
✓
FUTURE Pass
85/100
Analyst outlook: 6 / 8 analysts rate XXII as buy (75%). Analyst consensus target is $83 (+3948.8% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
XXII: Net profit margin is -28.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range1.95-841.8
Volume13.05K
Avg Volume (30D)41.63K
Market Cap$342.17K
Beta (1Y)1.12
Share Statistics
EPS (TTM)-52.87
Shares Outstanding$184.07K
IPO Date2011-01-26
Employees56
CEODaniel A. Otto
Financial Highlights & Ratios
Revenue (TTM)$17.59M
Gross Profit$-3.56M
EBITDA$-10.26M
Net Income$-5.05M
Operating Income$-11.42M
Total Cash$7.15M
Total Debt$4.21M
Net Debt$-2.94M
Total Assets$27.02M
Price / Earnings (P/E)-0
Price / Sales (P/S)0.02
Analyst Forecast
1Y Price Target$82.50
Target High$90.00
Target Low$75.00
Upside+3,924.4%
Rating ConsensusBuy
Analysts Covering8
Buy 75% Hold 25% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS90137F6088

Price Chart

Track all markets on TradingView
XXII
22nd Century Group, Inc. ↗  ·  NASDAQ Capital Marke
Consumer Defensive • Tobacco
1.95 52WK RANGE 841.80

People Also View

PM
PM
Philip Morris International Inc.
$159.47
-2.02%
 JAPAY
JAPAY
Japan Tobacco Inc.
$18.63
-0.69%
 IMBBY
IMBBY
Imperial Brands PLC
$39.85
-4.60%
 PHJMF
PHJMF
PT Hanjaya Mandala Sampoerna Tbk
$0.04
-29.17%
 RLX
RLX
RLX Technology Inc.
$2.17
+0.46%
 VGR
VGR
Vector Group Ltd.
$14.99
+0.20%
 TPB
TPB
Turning Point Brands, Inc.
$81.51
-2.08%
 UVV
UVV
Universal Corporation
$52.53
-1.57%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message